# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-000779
Filing Date
2025-02-11
Accepted
2025-02-11 07:00:25
Documents
63
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | epix-20241231x10q.htm iXBRL | 10-Q | 1170824
2 | EX-31.1 | epix-20241231xex31d1.htm | EX-31.1 | 7030
3 | EX-31.2 | epix-20241231xex31d2.htm | EX-31.2 | 7020
4 | EX-32.1 | epix-20241231xex32d1.htm | EX-32.1 | 9114
5 | GRAPHIC | epix-20241231x10q001.jpg | GRAPHIC | 17235
6 | GRAPHIC | epix-20241231x10q003.jpg | GRAPHIC | 38174
7 | GRAPHIC | epix-20241231x10q004.jpg | GRAPHIC | 38064
| Complete submission text file | 0001558370-25-000779.txt |  | 4793584

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | EX-101.SCH | epix-20241231.xsd | EX-101.SCH | 32884
9 | EX-101.CAL | epix-20241231_cal.xml | EX-101.CAL | 35023
10 | EX-101.DEF | epix-20241231_def.xml | EX-101.DEF | 100075
11 | EX-101.LAB | epix-20241231_lab.xml | EX-101.LAB | 273518
12 | EX-101.PRE | epix-20241231_pre.xml | EX-101.PRE | 201186
65 | EXTRACTED XBRL INSTANCE DOCUMENT | epix-20241231x10q_htm.xml | XML | 639267

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 25607645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)